Cargando…
Circulating Neprilysin Level Predicts the Risk of Cardiovascular Events in Hemodialysis Patients
Background: Neprilysin inhibition has demonstrated impressive benefits in heart failure treatment, and is the current focus of interest in cardiovascular (CV) and kidney diseases. However, the role of circulating neprilysin as a biomarker for CV events is unclear in hemodialysis (HD) patients. Metho...
Autores principales: | Hwang, Hyeon Seok, Kim, Jin Sug, Kim, Yang Gyun, Lee, Yu Ho, Lee, Dong-Young, Ahn, Shin Young, Moon, Ju-Young, Lee, Sang-Ho, Ko, Gang-Jee, Jeong, Kyung Hwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239158/ https://www.ncbi.nlm.nih.gov/pubmed/34212014 http://dx.doi.org/10.3389/fcvm.2021.684297 |
Ejemplares similares
-
Circulating Vascular Adhesion Protein-1 Level Predicts the Risk of Cardiovascular Events and Mortality in Hemodialysis Patients
por: Kim, Dae Kyu, et al.
Publicado: (2021) -
Circulating PCSK9 Level and Risk of Cardiovascular Events and Death in Hemodialysis Patients
por: Hwang, Hyeon Seok, et al.
Publicado: (2020) -
Clinical implications of circulating follistatin-like protein-1 in hemodialysis patients
por: Kim, Dae Kyu, et al.
Publicado: (2023) -
Gait speed and handgrip strength as predictors of all-cause mortality and cardiovascular events in hemodialysis patients
por: Lee, Yu Ho, et al.
Publicado: (2020) -
Plasma Endocan as a Predictor of Cardiovascular Event in Patients with End-Stage Renal Disease on Hemodialysis
por: Kim, Jin Sug, et al.
Publicado: (2020)